A Study of Obinutuzumab + Bendamustine (BG) in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Public ClinicalTrials.gov record NCT02320487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Open-Label Study of Obinutuzumab Plus Bendamustine (BG) in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, open-label, multicenter study to evaluate the safety and efficacy of BG induction therapy in participants with previously untreated CLL. The anticipated time on study treatment is 24 weeks.
Study identification
- NCT ID
- NCT02320487
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 102 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2015 (Actual)
- Primary completion
- Nov 7, 2016 (Actual)
- Completion
- Feb 6, 2019 (Actual)
- Last update posted
- Feb 11, 2020
2015 – 2019
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clearview Cancer Institute | Huntsville | Alabama | 35805 | — |
| Southern Cancer Center - Mobile | Mobile | Alabama | 36608 | — |
| Ironwood Cancer TX & Rsch Ctrs | Chandler | Arizona | 85224 | — |
| Arizona Oncology Associates, PC - HAL | Tempe | Arizona | 85284 | — |
| Arizona Oncology Associates, PC - HOPE | Tucson | Arizona | 85704 | — |
| Highlands Oncology Group | Fayetteville | Arkansas | 72703 | — |
| Rocky Mountain Cancer Center - Aurora | Aurora | Colorado | 80012 | — |
| Cancer Care and Hematology | Fort Collins | Colorado | 80528 | — |
| Piedmont Cancer Institute, PC | Atlanta | Georgia | 30318 | — |
| Northwest Georgia Oncology Centers PC - Marietta | Marietta | Georgia | 30060 | — |
| Cancer Care & Hematology; Specialists of Chicagoland | Niles | Illinois | 60714 | — |
| Fort Wayne Med Oncology & Hematology Inc | Fort Wayne | Indiana | 46845 | — |
| Center For Cancer and Blood Disorders | Bethesda | Maryland | 20817 | — |
| Regional Cancer Care Associates LLC - Morristown | Morristown | New Jersey | 07962 | — |
| San Juan Oncology Associates | Farmington | New Mexico | 87401 | — |
| Stony Brook University Hospital | Stony Brook | New York | 11794 | — |
| Northwest Cancer Specialists - Portland (N Broadway) | Portland | Oregon | 97227 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Willamette Valley Cancer Insitute and Research Center | Springfield | Oregon | 97477 | — |
| Texas Oncology-Arlington | Arlington | Texas | 76012 | — |
| Texas Oncology-Tyler | Irving | Texas | 75063 | — |
| Joe Arrington Cancer Research & Treatment Center | Lubbock | Texas | 79410 | — |
| Cancer Care Centers of South Texas-HOAST - San Antonio | New Braunfels | Texas | 78130 | — |
| Northern Utah Associates | Ogden | Utah | 84403 | — |
| Virginia Cancer Specialists, PC | Fairfax | Virginia | 22031 | — |
| Yakima Valley Memorial Hospital/North Star Lodge | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02320487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 11, 2020 · Synced Nov 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02320487 live on ClinicalTrials.gov.